Haubitz M - Search Results

1

[KDIGO 2021 guideline glomerulonephritis - focus on ANCA-associated vasculitides and anti-glomerular basement membrane glomerulonephritis].

de Groot K, Haubitz M, Rupprecht HD, Schönermarck U. de Groot K, et al. Among authors: haubitz m. Dtsch Med Wochenschr. 2021 Nov;146(23):1552-1558. doi: 10.1055/a-1206-2480. Epub 2021 Nov 26. Dtsch Med Wochenschr. 2021. PMID: 34826843 German.

2

[Anti B-cell-antibody treatment for maintenance of remission in granulomatosis with polyangiitis and microscopic polyangiitis].

de Groot K, Aries PM, Haubitz M, Hellmich B, Lamprecht P, Thiel J. de Groot K, et al. Among authors: haubitz m. Dtsch Med Wochenschr. 2020 Jan;145(1):40-46. doi: 10.1055/a-1060-2736. Epub 2020 Jan 8. Dtsch Med Wochenschr. 2020. PMID: 31914468 Review. German.

3

[B-cell targeted therapy in patients with granulomatosis with polyangiitis and microscopic polyangiitis].

Moosig F, Aries PM, de Groot K, Haubitz M, Hellmich B, Iking-Konert C, Wagner AD, Zänker M. Moosig F, et al. Among authors: haubitz m. Dtsch Med Wochenschr. 2014 Oct;139(44):2248-53. doi: 10.1055/s-0034-1387327. Epub 2014 Oct 21. Dtsch Med Wochenschr. 2014. PMID: 25334077 Review. German. No abstract available.

4

Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis.

Haubitz M, de Groot K. Haubitz M, et al. Clin Nephrol. 2002 Jun;57(6):421-4. doi: 10.5414/cnp57421. Clin Nephrol. 2002. PMID: 12078944

5

Avacopan for the Treatment of ANCA-Associated Vasculitis.

Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Jayne DRW, et al. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. N Engl J Med. 2021. PMID: 33596356 Clinical Trial.

6

[ANCA-associated vasculitis. New concepts and strategies in therapy].

de Groot K, Haubitz M, Haller H. de Groot K, et al. Among authors: haubitz m. Internist (Berl). 2000 Oct;41(10):1112-9. doi: 10.1007/s001080050670. Internist (Berl). 2000. PMID: 11084898 Review. German. No abstract available.

7

Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis.

Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Woywodt A, et al. Among authors: haubitz m. Lancet. 2003 Jan 18;361(9353):206-10. doi: 10.1016/S0140-6736(03)12269-6. Lancet. 2003. PMID: 12547543

8

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Haubitz M, Good DM, Woywodt A, Haller H, Rupprecht H, Theodorescu D, Dakna M, Coon JJ, Mischak H. Haubitz M, et al. Mol Cell Proteomics. 2009 Oct;8(10):2296-307. doi: 10.1074/mcp.M800529-MCP200. Epub 2009 Jun 28. Mol Cell Proteomics. 2009. PMID: 19564150 Free PMC article.

9

[Renal manifestation in ANCA-associated vasculitis].

Haubitz M. Haubitz M. Dtsch Med Wochenschr. 2018 Jan;143(2):79-88. doi: 10.1055/s-0043-106566. Epub 2018 Jan 22. Dtsch Med Wochenschr. 2018. PMID: 29359288 German.

10

[Rapid progressive glomerulonephritis].

Haubitz M. Haubitz M. Internist (Berl). 2019 May;60(5):478-484. doi: 10.1007/s00108-019-0575-x. Internist (Berl). 2019. PMID: 30868251 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page